Appointment of N+1 Singer as Joint Broker

RNS Number : 2347W
Directa Plus PLC
31 July 2018
 

31 July 2018

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Appointment of N+1 Singer as Joint Broker

 

Directa Plus plc (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as the Company's Joint Broker with immediate effect.

 

Cantor Fitzgerald Europe remains the Company's Nominated Adviser and Joint Broker.

 

Enquiries

 

Directa Plus plc

 

Giulio Cesareo, CEO

Marco Ferrari, CFO

+39 02 36714458

 

 

 

N+1 Singer

Mark Taylor, Lauren Kettle

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

 

 

+44 20 7496 3069

Marc Milmo, David Foreman (Corporate Finance)

Alex Pollen, Caspar Shand Kydd (Sales)

+44 20 7894 7000

 

 

 

Luther Pendragon (Financial PR)

 

Harry Chathli, Claire Norbury, Alexis Gore

+44 20 7618 9100

 

About Directa Plus

 

Directa Plus is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets worldwide. By incorporating Directa Plus' unique graphene blends, identified by the G+ brand, its customers can enhance the performance of their end products without significantly increasing their cost. Directa Plus graphene-based products are natural, chemical-free, sustainably produced and tailored to specific customer requirements for commercial applications such as smart textiles, tyres, composite materials and environmental solutions. 

 

Established in 2005, the Company has a patented technology process and a portfolio of product and application patents. It produces its graphene-based products at its own factory in Lomazzo, Italy, with a scalable and exportable manufacturing model enabling the set-up of additional production at customer locations to reduce transport costs, waste and time-to-utilisation. Directa Plus partners with customers to enable them to offer the high-performance benefits of graphene in their own products.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPWGUQAMUPRPUU
UK 100

Latest directors dealings